Home
About
Overview
Sharing Data
ORCID
Help
History (56)
Cost analysis of second-line therapies for platinum-refractory ovarian cancer: reimbursement dilemmas for Medicare patients.
Pitheciidae
Electrowetting
Vintafolide: a novel targeted agent for epithelial ovarian cancer.
LY141865: a relatively selective DA2 agonist with complex ocular activity.
See All 56 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
LY141865: a relatively selective DA2 agonist with complex ocular activity.
LY141865: a relatively selective DA2 agonist with complex ocular activity. J Ocul Pharmacol. 1988; 4(1):19-28.
View in:
PubMed
subject areas
Animals
Cebus
Dopamine Agents
Ergolines
Eye
Intraocular Pressure
Male
Mydriatics
Ocular Hypertension
Pupil
Quinpirole
Rabbits
Sulpiride
Sympathectomy, Chemical
authors with profiles
David E. Potter